Celebrating 50 Years of Service


From a small single office practice in Birmingham over 50 years ago, ENT Associates of Alabama has grown into Alabama’s largest Ear, Nose and Throat medical practice in the state. Today, with 9 offices and 15 doctors, ENT Associates covers central Alabama with the very best in healthcare availability.

Our growth isn’t accidental, it has come about through the dedication of doctors and staff to a single thought… “Experience Matters,” both our years of experience in treating patience with best practices and your actual experience with us are the keys to our success and your outcome. We thank you, our patients and caretakers for our success and look forward to another 50 years.

Dr. Alice Morgan leads the way for women in Otolaryngology

The efforts of women like Dr. Morgan and Dr. Grayson continue to shine a light on what women can accomplish, as well as women’s multi-faceted abilities to lead, inspire, and impact those around them. The two continue to inspire women to pursue their dreams despite the barriers and challenges.


Click On This Link For The Complete Article:


We are pleased to announce that ENT Associates of Alabama, P.C. has opened a new location – located in the Simon Williamson Building on the campus of Princeton Baptist Medical Center.


Our goal is always to provide exceptional same day care to our patients.  We are excited that this new location gives us 9 offices to better serve you and your family.


Our Princeton office will be open Mondays and Wednesdays from 8:00-5:00.

Please call to schedule an appointment:  (205)558-6237 or  1(888)368-5020.

Office Hours Effective 03/08/21 – New Hours Listed Below

All of us at ENT Associates of Alabama, P.C. are extremely grateful to our patients for their loyalty and patience during this crisis, and we are working hard to be available to you. As always, the health and safety of our staff, our patients and their families are our top priority, and we will continue to follow the CDC recommendations for proper disinfecting and disease prevention.

As recommended by the State –

All patients are required to wear a mask for their appointment and while in our lobby.


During these difficult times, it is even more critical that those in need of healthcare services have access to treatment, while practicing social distancing and exposing them as little as possible to any potential infections.  In order to continue serving our patients and be considerate of their safety, we are temporarily limiting our appointment hours during this crisis as follows:

Hours of Operation:

Saint Vincent’s Downtown Office: open Monday and Tuesday 8:00 AM to 5:00 PM, Wednesday 7:00AM to 5:00PM, Thursday 7:00AM to 7:00PM, and Friday 7:00 AM until Noon
Saturday 7:00 AM until 11:00 AM Every Saturday

Grandview Office: open Monday and Tuesday 7:30AM to 5:00PM, Wednesday 8:00 to 5:00PM, Thursday 8:00 AM to 7:00 PM, and Friday 7:00 AM until Noon

Jasper Office: open Monday through Thursday 8:00 AM to 5:00 PM and Friday 8:00 AM until Noon

Cullman Office: open Monday through Thursday 8:00 AM to 5:00 PM and Friday 8:00 AM until Noon

Trussville-Saint Vincent’s East Office: open Monday through Wednesday 8:00 AM to 5:00 PM, Thursday 8:00AM to 7:00PM, and Friday 7:00 AM until Noon

Shelby County/Alabaster Office: open Monday 8:00 AM to 5:00 PM, Tuesday 8:30 to 7:00PM, Wednesday 7:00AM to 5:00PM, Thursday 8:00AM to 5:00PM, and Friday 8:00 AM until Noon

Gardendale Office: open Monday through Wednesday 8:00 AM to 5:00 PM, Thursday 8:00AM to 7:00PM, and Friday 7:00 AM until Noon

Pell City Office: open Tuesday 1:00 PM to 5:00 PM and Friday 8:00 AM until Noon

Princeton Office Location: open Wednesday 8AM until 5:00 PM


Telehealth Appointments are available during normal office hours.


Please call for appointments or additional information (205) 933-9236

By Christopher Clark, MD

As Seen In Birmingham Medical News

Obstructive Sleep Apnea (OSA) is a common problem affecting nearly one-third of the adult population. The long-term health effects of untreated OSA are beginning to become established and are frightening: increased risk of cardiovascular disease, stroke, dementia, pulmonary hypertension.

The etiology of OSA is multifactorial and related to the interplay of anatomic obstruction as well as physiologic relaxation of the upper airway during sleep. The primary goal of treatment for OSA is to relieve anatomic obstruction of the upper airway. This has most commonly and most effectively been achieved by the use of continuous positive airway pressure (CPAP) therapy. There are, however, many difficulties with tolerance of CPAP which may be easily overcome after identifying and treating areas of often overlooked anatomic obstruction.

Otolaryngology (ENT) as a medical and surgical subspecialty has the unique opportunity to directly identify and treat upper airway obstruction as it may relate to nasal, nasopharyngeal, oropharyngeal, oral, or supraglottic anatomy. Specific sites of obstruction that may be identified with in-office flexible laryngoscopy include:
• Nasal obstruction resulting from: External/Internal valve collapse, nasal septal deviation, turbinate hypertrophy, chronic rhinosinusitis/nasal polyps, or adenoid hypertrophy
• Oropharyngeal obstruction, resulting from tonsillar hypertrophy, long/hypotonic soft palate, or retropulsion/collapse of the base of tongue
• Supraglottic obstruction resulting from lingual tonsillar hypertrophy, epiglottic cysts, etc
• Laryngeal or tracheal obstruction from upper airway stenosis

The widespread adoption of Drug Induced Sleep Endoscopy has allowed further qualification and quantification of upper airway obstruction and assists with identifying potential procedures that would most effectively improve CPAP tolerance. This simple, approximately 15 minute long procedure is performed in the operating room with the assistance of Anesthesiologists.

Titration of sedative medication which usually consist of propofol, midazolam and/or dexmedetomidine is administered until the physiological effects of sleep become manifest, namely the demonstration of upper airway obstruction. A flexible laryngoscope is then inserted into the nasal cavities and observation is undertaken at each potential level of obstruction. Any sites of obstruction would be appropriately documented and addressed either during the same anesthetic event, or catalogued and submitted for discussion with the patient to be addressed at another encounter.

Potential surgical treatment options for upper airway obstruction may include:
• Nasal: Nasal Valve Collapse Repair (Functional Rhinoplasty), Septoplasty, Turbinate Submucous Resection, Sinus Surgery for removal of polyps
• Oropharyngeal: Tonsillectomy, Uvulopalatopharyngoplasty (UPPP), Expansion Pharyngoplasty, Base of Tongue Suspension, Lingual Tonsillar Coblation, Hyoid Suspension
• Supraglottic/Glottic: Microsuspension laryngoscopy with removal of any obstructive lesions or masses. Upper airway stenosis is most commonly treated with endoscopic airway dilation.

Perhaps the most promising and unique procedure to treat OSA that is directly performed by ENT doctors involves the principle of hypoglossal nerve stimulation during sleep. Stimulation of the hypoglossal nerve provides tone to the intrinsic tongue musculature and prevents upper airway collapse in the first place.

INSPIRE is the only FDA-approved implantable device for the treatment of moderate to severe OSA. A small power source and sensor is placed during a short, outpatient surgery, and therapy may be initiated without the requirement of CPAP masks or hoses. Recent studies have demonstrated a 79 percent reduction in AHI (Apnea/Hypopnea Index), and five-year study data has maintained that reduction.

There are many variables in the treatment of OSA, including many sites of easily treatable obstruction. Simple ENT procedures may improve CPAP tolerance, or as in the case of Hypoglossal Nerve Stimulation, may free patients from CPAP masks and hoses entirely.

All patients evaluated in sleep clinics would benefit greatly from ENT evaluation as part of their multidisciplinary (Sleep Medicine, ENT, Dentistry/OMFS, Diet & Weight Management) workup for OSA treatment.

At ENT Associates of Alabama we take employee appreciation very seriously. Each year we celebrate our employees and their contributions to the practice. We want to say thanks to all ENT Associates employees for another outstanding year.

Dr. H. Baltzer LeJeune was born and raised in New Orleans, Louisiana. He attended Washington & Lee University where he served on the Executive Committee and was selected for membership in both ODK and AED, the premedical honor society. He also received the Kenneth P. Stevens and Gary H. Dobbs award (Biology), graduating with honors. Dr. LeJeune attended LSU School of Medicine in New Orleans where he was a member of the Aesculapian Society, graduating in 1991.
Dr. LeJeune received the Outstanding Service Award (Touro Infirmary) in his intern year and completed his residency training in Otolaryngology at Tulane University in 1997. He was recruited from residency to join Birmingham Ear Nose & Throat Group, where he practiced for 20 years. He has now joined ENT Associates of Alabama, P.C, and will be seeing patients at the St. Vincent’s Birmingham and Gardendale locations. In his free time, Dr. LeJeune enjoys spending time with his wife and 3 children and enjoys hunting, golf and sailing when time permits.

Dr. Christopher Clark completed his undergraduate training in an early-entry program offered through the school of Veterinary Medicine at Mississippi State University – majoring in Microbiology and Religion. Thereafter, he completed Medical School at the University of Mississippi; and finished postgraduate training through the University of Texas.

Following residency, Dr. Clark sought advanced Fellowship training in NeuroRhinology (diseases of the nose and sinuses) and Allergy through the University of Texas – Southwestern Medical Center. In addition to his Fellowship training in Nasal/Sinus and allergic disease, he welcomes all adult and pediatric patients and has interest in a wide range of surgical and nonsurgical disorders of the head and neck, including: plastic and reconstructive surgery, rhinoplasty (functional nasal reconstruction), head and neck cancer, thyroid/parathyroid disease, salivary gland disease, sleep apnea, airway and voice disorders, chronic ear disease, and hearing loss.

Dr. Clark and his wife, Haley, live in Mountain Brook with their two children, Addison and Elliott. Haley is a Radiologist specializing in Women’s Imaging at several Birmingham area hospitals. Together, they love reading, cooking, hiking/biking/swimming and are actively involved with their local church.

ENT Associates of Alabama is excited to be on the cutting edge of nasal polyp treatment by offering the SINUVA sinus implant, recently approved by the FDA to treat nasal polyps in adults who have had previous ethmoid sinus surgery (ESS). SINUVA is a non-surgical option that is placed during a routine physician office visit. It is clinically proven to reduce nasal congestion and polyps. Patients with a known hypersensitivity to the mometasone furoate drug or any of the ingredients in SINUVA should not use SINUVA. The area around SINUVA should be monitored by a physician for any signs of bleeding, irritation, infection, or perforation. For full safety info, visit www.SINUVA.com.

News and Information